G-CSF for Fever and Neutropenia Induced by Chemotherapy

To the Editor: As a clinical hematologist, I am glad to see granulocyte colony-stimulating factor (G-CSF) become available for clinical use. However, in view of a recent critique of the cost effectiveness of intravenous preparations of immune globulin in the treatment of chronic lymphocytic leukemia...

Full description

Saved in:

Bibliographic Details
Published in:	The New England journal of medicine Vol. 326; no. 4; pp. 269 - 270
Main Author:	Hamm, J T
Format:	Journal Article
Language:	English
Published:	United States Massachusetts Medical Society 23-01-1992
Subjects:	Antineoplastic Agents - administration & dosage Carcinoma, Small Cell - drug therapy Granulocyte Colony-Stimulating Factor - therapeutic use Humans Lung Neoplasms - drug therapy Neutropenia - chemically induced
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
Summary:	To the Editor: As a clinical hematologist, I am glad to see granulocyte colony-stimulating factor (G-CSF) become available for clinical use. However, in view of a recent critique of the cost effectiveness of intravenous preparations of immune globulin in the treatment of chronic lymphocytic leukemia, 1 I was surprised to see the Journal publish without editorial comment an article on G-CSF, by Crawford et al. (July 18 issue), 2 containing the statement that in addition to the clinical impact of G-CSF, "there may be a substantial economic impact" — the implication being that the economic impact would be favorable in that the . . .
Bibliography:	SourceType-Other Sources-1 content type line 63 ObjectType-Correspondence-1 ObjectType-Commentary-2 ObjectType-Article-2 ObjectType-Commentary-4 ObjectType-Feature-1 ObjectType-Correspondence-3
ISSN:	0028-4793 1533-4406
DOI:	10.1056/NEJM199201233260412